SURMOUNT-5 is the only direct head-to-head trial among the three
BPC-157 BPC-157 was the most frequently represented peptide agent in musculoskeletal research
A careful review with a qualified clinician can help separate marketing language from evidence-based care, including whether structured weight loss treatment might be more suitable for some individuals
Similar to other GLP-1 medications, the most common side effects in clinical trials were gastrointestinal issues, such as nausea, vomiting, constipation, diarrhea, and acid reflux
doi: 10.1038/s44161-024-00453-9
If you do not allow these cookies, some or all of these services may not function properly